• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzylamines 2-benzylaminopyridines

Recent Advances in the Study of N-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine (CAS: 1350918-91-0)

N-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine (CAS: 1350918-91-0) is a boronic acid derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry. This compound is particularly notable for its role as a key intermediate in the synthesis of various biologically active molecules, including kinase inhibitors and other therapeutic agents. Recent studies have explored its potential applications in drug discovery and development, with a focus on its unique chemical properties and reactivity.

One of the most promising aspects of this compound is its utility in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in organic synthesis. The presence of the boronic ester moiety in N-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine makes it an excellent candidate for such reactions, enabling the efficient construction of complex molecular architectures. Recent research has demonstrated its effectiveness in the synthesis of novel pyridine-based compounds, which are of interest for their potential pharmacological activities.

In addition to its synthetic applications, studies have also investigated the biological activity of N-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine and its derivatives. Preliminary findings suggest that these compounds may exhibit inhibitory effects on certain protein kinases, which are implicated in various diseases, including cancer and inflammatory disorders. Further mechanistic studies are underway to elucidate the precise molecular targets and pathways involved.

The stability and handling of N-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine have also been subjects of recent investigation. Researchers have developed optimized protocols for its storage and use, ensuring its reliability in both laboratory and industrial settings. These advancements are critical for scaling up production and facilitating its incorporation into larger drug discovery campaigns.

Looking ahead, the continued exploration of N-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine and related compounds holds great promise for the development of new therapeutic agents. Future research directions may include the design of more potent and selective derivatives, as well as the investigation of their pharmacokinetic and pharmacodynamic properties. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to fully realize the potential of this versatile compound.

• 1402166-06-6(2-(piperidin-1-yl)-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1259445-03-8(2-(Pyrrolidin-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1015242-03-1(1-Benzyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine)
• 1073354-30-9(N-Benzyl-N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1257554-24-7(Isopropyl-methyl-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-amine)
• 1073354-32-1(N-(4-Methylbenzyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1321518-05-1(N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-amine)
• 1073354-27-4(6-(benzylamino)pyridine-3-boronic acid pinacol ester)
• 957198-31-1(2-(Piperazin-1-yl)pyridine-4-boronic Acid Pinacol Ester)
• 832114-09-7(1-methyl-4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine)